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Therapeutic Phlebotomy Related to 
Polycythemia Vera and Hemochromatosis 
Dylan Cimo, Nathan Miller, Emily Neal 
Cedarville University School of Nursing 
PATIENT CARE ISSUE 
• Therapeutic phlebotomy as first-line treatment of blood disorders 
• Blood disorders: Polycythemia Vera and Hemochromatosis   
• Other treatments include Hydroxyurea, Interferon Alpha, Erythrocyte 
Apheresis, Aspirin, and Deferoxamine 
• Some medical professionals prefer alternative treatments to 
phlebotomy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Question: Is therapeutic phlebotomy the best treatment option for Polycythemia 
Vera and Hemochromatosis? 
 
P: Patients affected by Polycythemia Vera and Hemochromatosis 
I: Therapeutic Phlebotomy 
C: Pharmacologic treatments 
O: Relieve symptoms more successfully with fewer side effects 
EVIDENCE-BASED PRACTICE QUESTION 
• Therapeutic phlebotomy is currently considered first-line treatment for multiple 
blood disorders (Cook, 2010) 
• Medications were found to have a higher incidence of adverse affects (Siddique, 
2012) 
• Therapeutic Phlebotomy is the cheapest form of treatment (Siddique, 2012) 
 
RESULTS & METHODS 
SYNTHESIS OF EVIDENCE 
•Standard of care at Springfield Regional Hospital 
•“A procedure called phlebotomy is the best method for removing excess iron 
from the body,” (Dugdale, 2008)  
•Springfield Regional Hospital considers phlebotomy to be the best method for 
treating polycythemia vera (Dugdale, 2009) 
STANDARD OF CARE 
 
REGISTERED NURSE INTERVIEW 
•Paul and Amber, Registered Nurses at Springfield Regional Hospital 
•Neither RN had encountered a patient in need of  therapeutic phlebotomy on the 
Cardiac Step-down Unit 
• Problem-focused triggers 
• Identification of clinical problem: Therapeutic phlebotomy as first-line treatment 
for blood disorders 
•  There is not a sufficient research base 
• Practice is based on expert opinion and case reports 
• Springfield Regional Hospital implements therapeutic phlebotomy 
• Springfield Regional Hospital should continue implementing this practice based 
on the current research 
 
EVIDENCE-BASED PRACTICE RECOMMENDATIONS 
• RN interview did not indicate this topic as a major issue 
• There are not many current research articles on therapeutic phlebotomy 
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